AA
SGP

ALPS Advisors’s SpyGlass Pharma SGP Stock Holding History

ALPS Advisors’s Portfolio SGP Stock Details SGP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$755K Buy
+33,932
New +$736K ﹤0.01% 782

Other funds holding SGP

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

ALPS Advisors's SGP Position: Q2 2026 in Review

ALPS Advisors opened a new position in SpyGlass Pharma (SGP) in Q2 2026: 33,932 shares worth $755K. The stake represents ﹤0.01% of the portfolio and ranks #782 among its holdings.

9 funds tracked by Wall St. Rank hold SGP as of Q2 2026.

  • ALPS Advisors held 33,932 shares of SpyGlass Pharma worth $755K as of Q2 2026.
  • SpyGlass Pharma was a new ALPS Advisors position in Q2 2026.
  • SpyGlass Pharma made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #782 holding.
  • 9 funds tracked by Wall St. Rank held SpyGlass Pharma as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.